Home Trending Stocks What Has Been Driving G1 Therapeutics Inc. (GTHX) Stock Price Down?

What Has Been Driving G1 Therapeutics Inc. (GTHX) Stock Price Down?

G1 Therapeutics, Inc. (GTHX), is a commercial-stage biopharmaceutical company specializing in the discovery, development, and delivery of modern therapies, introduced two scientific posters at the International Society for Pharmacoeconomics and Outcomes Research focusing on the approximate economic repercussions of treating myelosuppression along with patients with high-stage small cell lung cancer.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

At last check-in after-market trading, shares of G1 Therapeutics Inc. (GTHX) declined -4.24% at $20.55. GTHX stock closed last session at $21.46, decreasing -2.05% or -$0.45. Shares of the company fluctuated between $20.56 and $22.00 throughout the day. The shares of G1 Therapeutics Inc. have advanced 8.71% in the last five days; however, they have lost -8.72% over the last month.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Measures For Treatment Of Myelosuppression

COSELA got approval by the FDA on February 12, 2021. The drug has been deemed suitable in reducing the incidence of chemotherapy-induced myelosuppression in adult patients affected with cancer when delivered before a platinum/etoposide-containing regimen or topotecan-containing regimen for high-stage small cell lung cancer.

The first poster depicts a cost-effective model forecasting the economic value from a U.S. commercial buyer’s perspective of using COSELA before chemotherapy in patients with high-stage small cell lung cancer. In accordance with the model, the anticipated total cost savings per patient could potentially be $15,006, an amount that is based on a forecast depletion in myelosuppressive unfavorable events (AEs) and their linked treatment expense.

The authors suggest that the model depicts that COSELA could potentially be an economically feasible innovation to facilitate ease and reduction in the incidence of myelosuppression in patients with ES-SCLC being administered with a platinum/etoposide-containing chemotherapy regimen.

The second poster establishes the impact of treatment-induced myelosuppression along Medicare patients affected with SCLC, hence providing the growing body of scientific evidence, depicting the essential health burden, financial toll, and quality of life effects of chemotherapy-induced myelosuppression.

Approximately 75% of patients treated with chemotherapy had been through anemia during the timeline studied. Neutropenia was diagnosed in 45.2% of chemotherapy-treated patients generally. Thrombocytopenia was reported in 27.0% of patients treated with chemotherapy overall. Pancytopenia was also seen in 24.4% of patients overall. During the same time frame, 74.3% of chemotherapy-treated patients had been through a minimum of one inpatient admission linked with myelosuppression.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Several adverse reactions to COSELA such as fatigue, hypocalcaemia, hypokalaemia and hypophosphatemia combined with acute drug hypersensitivity reactions and embryo-fetal toxicity has reduced investor interest, with GTHX stock price plummeting at last check.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Related News

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam